mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.06 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.08 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |
mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.08 |
mRNA |
GSK2636771 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.08 |
mRNA |
Platin |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.08 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.058 |
0.09 |
mRNA |
BYL-719 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.09 |